We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+4.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$43.6M
AUM Growth
-$1.72M
(-3.8%)
Cap. Flow
-$1.65M
Cap. Flow
% of AUM
-3.77%
Top 10 Holdings %
Top 10 Hldgs %
62.67%
Holding
57
New
2
Increased
10
Reduced
21
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NexGen Energy
NXE
|
+$3.92M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
+$882K |
| 3 |
BeyondSpring
BYSI
|
+$633K |
| 4 |
Corcept Therapeutics
CORT
|
+$584K |
| 5 |
Tower Semiconductor
TSEM
|
+$57.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$852K |
| 2 |
Amgen
AMGN
|
+$527K |
| 3 |
ADXS
Advaxis Inc
ADXS
|
+$502K |
| 4 |
MacroGenics
MGNX
|
+$311K |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$160K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.55% |
| 2 | Technology | 24.69% |
| 3 | Miscellaneous | 9.2% |
| 4 | Energy | 9.09% |
| 5 | Industrials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tower Semiconductor
TSEM
$25.1B
| $4.25M | 9.74% |
178,186
+2,453
| +1% | +$57.9K |
|
2
Ionis Pharmaceuticals
IONS
$9.65B
| $4.17M | 9.55% |
81,937
-1,462
| -2% | -$68.1K |
|
|
3
NexGen Energy
NXE
$7.19B
| $3.95M | 9.05% |
+1,802,732
| New | +$3.92M |
|
4
Apple
AAPL
$4.67T
| $3.02M | 6.93% |
83,968
-1,464
| -2% | -$54.1K |
|
|
PARAA
5
DELISTED
Paramount Global Class A
PARAA
| $2.87M | 6.57% |
44,971
-120
| -0.3% | -$7.83K |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $1.81M | 4.15% |
13,945
-37
| -0.3% | -$4.53K |
|
7
Alaska Air
ALK
$4.69B
| $1.78M | 4.08% |
19,832
-166
| -0.8% | -$14.6K |
|
8
Tesla
TSLA
$1.4T
| $1.66M | 3.79% |
68,700
-1,965
| -3% | -$43.3K |
|
|
9
Corcept Therapeutics
CORT
$12.1B
| $1.65M | 3.77% |
139,397
+53,692
| +63% | +$584K |
|
|
RTEC
10
DELISTED
Rudolph Technologies Inc
RTEC
| $1.62M | 3.72% |
70,977
+150
| +0.2% | +$3.57K |
|
11
Aflac
AFL
$58.8B
| $1.29M | 2.95% |
33,102
+56
| +0.2% | +$2.1K |
|
12
JetBlue
JBLU
$1.75B
| $1.04M | 2.39% |
45,764
-308
| -0.7% | -$6.77K |
|
|
AMRS
13
DELISTED
Amyris Inc.
AMRS
| $977K | 2.24% |
307,254
+163,470
| +114% | +$882K |
|
|
14
BeyondSpring
BYSI
$25.4M
| $914K | 2.09% |
+21,322
| New | +$633K |
|
15
Qualcomm
QCOM
$180B
| $889K | 2.04% |
16,099
-1,313
| -8% | -$73.4K |
|
16
Honeywell
HON
$66.4B
| $835K | 1.91% |
6,936
| – | – |
|
|
NTRP
17
DELISTED
Neurotrope, Inc. Common
NTRP
| $756K | 1.73% |
80,705
-10,760
| -12% | -$115K |
|
18
Helen of Troy
HELE
$661M
| $713K | 1.63% |
7,572
-36
| -0.5% | -$3.35K |
|
19
Onto Innovation
ONTO
$13.2B
| $713K | 1.63% |
28,179
-140
| -0.5% | -$3.95K |
|
20
Inovio Pharmaceuticals
INO
$148M
| $688K | 1.58% |
7,318
-759
| -9% | -$64.9K |
|
|
CPRX
21
DELISTED
Catalyst Pharmaceutical
CPRX
| $665K | 1.52% |
241,078
-675
| -0.3% | -$1.41K |
|
22
Philip Morris
PM
$284B
| $657K | 1.51% |
5,590
+42
| +0.8% | +$4.86K |
|
|
SF
23
Stifel
SF
$12.3B
| $626K | 1.43% |
30,656
| – | – |
|
|
ADXS
24
DELISTED
Advaxis Inc
ADXS
| $475K | 1.09% |
4,879
-4,287
| -47% | -$502K |
|
25
Alphabet (Google) Class C
GOOG
$4.1T
| $324K | 0.74% |
7,040
| – | – |
|
Similar funds
GC
ACM
SCP
HPM
IPHI
RRC
MCMC
PAPAIJV
Tanaka Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Tanaka Capital Management held 57 positions worth $43.6M, down 3.8% from $45.4M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Tanaka Capital Management withdrew a net $1.65M in Q2 2017, closing 4 positions and reducing 21 holdings. Its most notable exit was MacroGenics, an estimated $311K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Tanaka Capital Management opened a new position in NexGen Energy worth $3.95M.
- Tanaka Capital Management's largest Q2 2017 buy was NexGen Energy: 1,802,732 shares worth $3.95M.
- Tanaka Capital Management added most to Amyris Inc. in Q2 2017, an estimated $882K increase.
- Tanaka Capital Management's biggest Q2 2017 reduction was GE Aerospace, cutting an estimated $852K.
- Tanaka Capital Management fully exited MacroGenics in Q2 2017, selling an estimated $311K.
- Tanaka Capital Management's ten largest holdings make up 63% of its $43.6M portfolio in Q2 2017.
- Tanaka Capital Management opened 2 new positions and closed 4 in Q2 2017.
- Tanaka Capital Management's portfolio value fell 3.8% quarter-over-quarter to $43.6M.
Based on Tanaka Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.